information to advance treatments. "I would be wearing out multiple sets of shoes going from investigator to investigator, clinician to clinician" to collect this sort of patient data, McDonough was quoted as saying. Earlier in 2020, Inspire data was cited in a BJU International research paper about the effect of prostate cancer on sleep. In January 2021, Marina Ness, Inspire's Director of Research, was an author on a paper in European Urology Open Science, the Open Access journal of the European Urology family. In November 2019, Inspire teamed with Mayo Clinic on a Journal of Medical Internet Research study involving the use of statins, and memory loss. Earlier in 2019, an Inspire researcher was an author on a Journal of Medical Internet Research paper with researchers from the Food and Drug Administration. Also in 2019, Inspire collaborated with Isabelle Boutron, a professor of epidemiology at the Paris Descartes University and head of the INSERM- METHODS team within the Centre of Research in Epidemiology and Statistics (CRESS), on BioMed Central," a study about "spin" in healthcare news. In April 2018, an Inspire data scientist was an author of a Nature Genetics correspondence about ways to close the"terminology gap" between medical professionals and patients. Also in 2018, Inspire collaborated with ProPublica and Memorial Sloan Kettering Cancer Center in research that led to a paper in the Journal of Oncology Practice. Earlier that year, JAMA Oncology published a research letter, based on research involving Stanford University and Inspire. National Public Radio (NPR) reported on the Stanford/Inspire study with the article, How Social Media Can Reveal Overlooked Drug Reactions. In 2015, members of Inspire's lung cancer group self-organized and submitted a request that helped changed treatment guidelines from the National Comprehensive Cancer Network (NCCN). Health technology industry executive John Glaser cited Inspire in an industry magazine column citing the importance of healthcare social networks to clinical research. "In addition to helping patients find and take advantage of clinical trials, health care social networks also provide an opportunity for participant-led research," Glaser wrote, "in which members initiate new fields of study. For instance, Inspire members with spontaneous coronary artery dissection persuaded researchers at the Mayo Clinic to launch new research into the condition, which led to the creation of a SCAD registry, a key step in the further study of this rare disease. Indeed, there is tremendous potential for online patient communities to contribute to